We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




X-Ray Techniques Probe the Clostridium Difficile Surface Layer

By LabMedica International staff writers
Posted on 11 Mar 2009
A team of molecular microbiologists has begun to shed light on the structural mechanism used by the pathogenic bacterium Clostridium difficile to adhere to and infect human enteric tissue.

Investigators at Imperial College (London, United Kingdom) used X-ray crystallography techniques to produce both high- and low-resolution images of the C. More...
difficile surface layer (S-layer). The S-layer contains a high-molecular-weight S-layer protein (HMW SLP) and its low-molecular-weight partner protein (LMW SLP).

Results published in the March 1, 2009, issue of the journal Molecular Microbiology revealed that the two types of protein formed a tightly associated noncovalent complex, the H/L complex. The 2.4-angstrom X-ray crystal structure of a shortened derivative of the LMW SLP revealed two domains. Domain 1 had a two-layer sandwich architecture while domain 2, predicted to orientate towards the external environment, contained a novel fold.

Small-angle X-ray scattering analysis of the H/L complex showed an elongated molecule, with the two SLPs arranged "end-to-end" interacting with each other through a small contact area. The way the LMW SLPs - which showed high sequence diversity - were aligned revealed a core of conserved residues. This type of structure could reflect functional conservation, while allowing for immune evasion through the sequence variation.

Dr. Neil Fairweather, professor of cell and molecular biology at Imperial College said, "This is the first time anyone has gained detailed information about the molecular structure of [the] C. difficile protective 'jacket,' because analyzing the two protein components is painstakingly difficult work. We are confident that continuing this work to better understand the formation of this protective coat and its exact function will reveal new targets for effective drugs to beat this dangerous pathogen, and could even lead to an effective vaccine."

Related Links:
Imperial College



Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Senior researcher Annikka Polster collaborated with Nicola Pietro Montaldo in discovering the Parkinson’s Biomarkers (Photo courtesy of Chalmers University of Technology)

Newly-Identified Parkinson’s Biomarkers to Enable Early Diagnosis Via Blood Tests

Parkinson’s disease is a slow-progressing neurological disorder that disrupts the brain’s ability to control movement and is typically diagnosed after the age of 55. By the time motor symptoms appear,... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Noul’s AI-based cervical cancer diagnostic solution, miLab CER (Photo courtesy of Noul)

AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America

Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.